SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment

The study titled “SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment” explores the relationship between COVID-19 and diabetes, focusing on the infection of pancreatic β cells by SARS-CoV-2 and its consequences. Here’s a detailed summary: Background: The study investigates whether SARS-CoV-2, the virus causing COVID-19, can infect insulin-producing pancreatic β cells, potentially leading to diabetes. This is based on clinical observations of increased diabetes symptoms in COVID-19 patients​​. SARS-CoV-2 Entry Factors in β Cells: The study found that β cells in the pancreas express the SARS-CoV-2 receptors ACE2 and TMPRSS2, although at low levels. However, the expressions…